Загрузка...
Romosozumab: a novel bone anabolic treatment option for osteoporosis?
Research into the drug romosozumab began with the investigation of patients with excess bone formation. The understanding of the wingless-type mouse mammary tumor virus integration site (Wnt) signaling pathway in bone metabolism identified the negative regulator of bone mass sclerostin as a potentia...
Сохранить в:
| Опубликовано в: : | Wien Med Wochenschr |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Vienna
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7098919/ https://ncbi.nlm.nih.gov/pubmed/31858345 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10354-019-00721-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|